Photo of Ron Alting
R Indiana Senate · District 22 On the 2026 ballot

Sen. Ron Alting

Compare
Total votes
2,574
all sessions
Attendance
93%
181 missed
Near the chamber average
With party
93%
of cast votes
Lower than 87% of chamber peers
Bipartisan score
4%
crosses aisle rarely
Higher than 82% of chamber peers
Sponsored
559
bills & resolutions
Lower than 91% of chamber peers
Committees
2
assignments
559 bills and resolutions

Sponsored bills

Total
559
Primary
219
Co-sponsor
340
This page
559
matching current filters
Primary HB 1268
Passed · Indiana House · Lead sponsor
Return of lost pets to owners.

Requires an animal care facility to adopt policies and procedures that govern the return of lost or stray dogs and cats to the dog's or cat's owner. Provides animal care policies and procedures that an animal care facility may include to return lost or stray dogs and cats to the dog's or cat's owner.

Passed Mar 11, 2021 0 co-sponsors
Primary SR 28
Passed · Indiana Senate · Lead sponsor
Honoring Chairman David Cook.

A SENATE RESOLUTION honoring Chairman David Cook upon his retirement as Chairman of the Indiana Alcohol and Tobacco Commission, and congratulating him on his new position as the Indiana Inspector General.

Passed Mar 9, 2021 0 co-sponsors
Primary SB 43
Passed · Indiana Senate · Lead sponsor
Jumbo boats.

Modifies the definition of "jumbo boat" by removing the requirement that the vessel be approved by the United States Coast Guard. Provides that a holder of a: (1) boat beer permit who operates a jumbo boat may sell beer for carryout; (2) boat liquor permit who operates a jumbo boat may sell liquor for carryout; and (3) boat wine permit who operates a jumbo boat may sell wine for carryout.

Passed Mar 9, 2021 0 co-sponsors
Primary SB 131
Passed · Indiana Senate · Lead sponsor
Disclosures related to prescription drugs.

Beginning January 1, 2022, requires a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization contract to provide to a covered individual the maximum allowable cost of a generic drug on the written materials provided at the point of sale. Provides that if an agreement between a health plan and a pharmacy benefit manager that is entered into or renewed after December 31, 2021, provides that less than 85% of the estimated rebates will be deducted from the cost of prescription drugs before a covered individual's cost sharing requirement is determined, the pharmacy benefit manager must provide the policyholder with a notice on an annual basis that includes: (1) an explanation of what a rebate is; (2) an explanation of how rebates accrue to the health plan from the manufacturer; and (3) the aggregate amount of rebates that accrued to the health plan for prescription drugs dispensed under the policyholder's health plan for the previous year.

Passed Mar 4, 2021 0 co-sponsors
Primary SB 233
Passed · Indiana Senate · Lead sponsor
TANF eligibility.

Sets the income eligibility requirements for the Temporary Assistance for Needy Families (TANF) program at phased-in specified percentages of the federal income poverty level. Requires the division of family resources to amend the state TANF plan or take any other action necessary to implement the income requirements. Increases certain payment amounts under the TANF program. Requires the payments to be annually adjusted using the Social Security cost of living adjustment rate, but provides that the total adjustment in a year must be reduced to the extent the adjustment would result in the transfer to the Child Care and Development Fund grant program being less than the maximum allowable transfer under federal law. Authorizes emergency rulemaking concerning the payments. Repeals language requiring the division of family resources to apply a percentage reduction to the total needs of TANF applicants and recipients in computing TANF benefits.

Passed Mar 2, 2021 0 co-sponsors
Co-sponsor SB 1
Signed into law · Indiana Senate · Co-sponsor
Civil immunity related to COVID-19.

Provides civil tort immunity for damages arising from COVID-19 on the premises owned or operated by a person, on any premises on which the person or an employee or agent of the person provided property or services to the individual, or during an activity managed, organized, or sponsored by the person, except for an act or omission that constitutes gross negligence or willful or wanton misconduct (including fraud and intentionally tortious acts). Defines "COVID-19 protective product" and provides civil tort immunity for harm that results from the design, manufacture, labeling, sale, distribution, or donation of a COVID-19 protective product, except for an act or omission that constitutes gross negligence or willful or wanton misconduct (including fraud and intentionally tortious acts). Prohibits class action suits.

Signed into law Feb 18, 2021 1 co-sponsor
Showing 311 to 320 of 559 bills
Previous 1 … 31 32 33 … 56 Next